Selected research
Industry Research
Losartan Potassium Hydrochlorothiazide Tablet Industry Research Report 2026
Market perspective
The global Losartan Potassium Hydrochlorothiazide Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Losartan Potassium Hydrochlorothiazide Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Losartan Potassium Hydrochlorothiazide Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Losartan Potassium Hydrochlorothiazide Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Losartan Potassium Hydrochlorothiazide Tablet include Zhejiang NuoDe Pharmaceutical, Zhejiang Huahai Pharmaceutical, Dawnrays Pharmaceutical, Shandong XinYi Pharmaceutical, Lepu Medical Technology (Beijing), TIANJIN PHARMACEUTICAL DA REN TANG GROUP, Beijing Twinluck, Beijing Winsunny Pharmaceutical and Cozaar, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Losartan Potassium Hydrochlorothiazide Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Losartan Potassium Hydrochlorothiazide Tablet Market by Company
Zhejiang NuoDe Pharmaceutical
Zhejiang Huahai Pharmaceutical
Dawnrays Pharmaceutical
Shandong XinYi Pharmaceutical
Lepu Medical Technology (Beijing)
TIANJIN PHARMACEUTICAL DA REN TANG GROUP
Beijing Twinluck
Beijing Winsunny Pharmaceutical
Cozaar
Losartan Potassium Hydrochlorothiazide Tablet Segment by Type
50mg
100mg
Others
Losartan Potassium Hydrochlorothiazide Tablet Segment by Application
Elderly
Children
Adult
Losartan Potassium Hydrochlorothiazide Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Losartan Potassium Hydrochlorothiazide Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Losartan Potassium Hydrochlorothiazide Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Losartan Potassium Hydrochlorothiazide Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Losartan Potassium Hydrochlorothiazide Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Losartan Potassium Hydrochlorothiazide Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Losartan Potassium Hydrochlorothiazide Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 100mg
- Others
Applications
- Elderly
- Children
- Adult
Companies covered
- Zhejiang NuoDe Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Dawnrays Pharmaceutical
- Shandong XinYi Pharmaceutical
- Lepu Medical Technology (Beijing)
- TIANJIN PHARMACEUTICAL DA REN TANG GROUP
- Beijing Twinluck
- Beijing Winsunny Pharmaceutical
- Cozaar
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Market Size (2021-2032)
- 2.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales (2021-2032)
- 2.2.3 Global Losartan Potassium Hydrochlorothiazide Tablet Market Average Price (2021-2032)
- 2.3 Losartan Potassium Hydrochlorothiazide Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50mg
- 2.3.3 100mg
- 2.3.4 Others
- 2.4 Losartan Potassium Hydrochlorothiazide Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Elderly
- 2.4.3 Children
- 2.4.4 Adult
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Losartan Potassium Hydrochlorothiazide Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Losartan Potassium Hydrochlorothiazide Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Losartan Potassium Hydrochlorothiazide Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Losartan Potassium Hydrochlorothiazide Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Losartan Potassium Hydrochlorothiazide Tablet, Product Type & Application
- 3.8 Global Manufacturers of Losartan Potassium Hydrochlorothiazide Tablet, Established Date
- 3.9 Global Losartan Potassium Hydrochlorothiazide Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang NuoDe Pharmaceutical
- 4.1.1 Zhejiang NuoDe Pharmaceutical Company Information
- 4.1.2 Zhejiang NuoDe Pharmaceutical Business Overview
- 4.1.3 Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang NuoDe Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.1.5 Zhejiang NuoDe Pharmaceutical Recent Developments
- 4.2 Zhejiang Huahai Pharmaceutical
- 4.2.1 Zhejiang Huahai Pharmaceutical Company Information
- 4.2.2 Zhejiang Huahai Pharmaceutical Business Overview
- 4.2.3 Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zhejiang Huahai Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 4.3 Dawnrays Pharmaceutical
- 4.3.1 Dawnrays Pharmaceutical Company Information
- 4.3.2 Dawnrays Pharmaceutical Business Overview
- 4.3.3 Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dawnrays Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.3.5 Dawnrays Pharmaceutical Recent Developments
- 4.4 Shandong XinYi Pharmaceutical
- 4.4.1 Shandong XinYi Pharmaceutical Company Information
- 4.4.2 Shandong XinYi Pharmaceutical Business Overview
- 4.4.3 Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shandong XinYi Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.4.5 Shandong XinYi Pharmaceutical Recent Developments
- 4.5 Lepu Medical Technology (Beijing)
- 4.5.1 Lepu Medical Technology (Beijing) Company Information
- 4.5.2 Lepu Medical Technology (Beijing) Business Overview
- 4.5.3 Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lepu Medical Technology (Beijing) Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.5.5 Lepu Medical Technology (Beijing) Recent Developments
- 4.6 TIANJIN PHARMACEUTICAL DA REN TANG GROUP
- 4.6.1 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Company Information
- 4.6.2 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Business Overview
- 4.6.3 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.6.5 TIANJIN PHARMACEUTICAL DA REN TANG GROUP Recent Developments
- 4.7 Beijing Twinluck
- 4.7.1 Beijing Twinluck Company Information
- 4.7.2 Beijing Twinluck Business Overview
- 4.7.3 Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Beijing Twinluck Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.7.5 Beijing Twinluck Recent Developments
- 4.8 Beijing Winsunny Pharmaceutical
- 4.8.1 Beijing Winsunny Pharmaceutical Company Information
- 4.8.2 Beijing Winsunny Pharmaceutical Business Overview
- 4.8.3 Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Beijing Winsunny Pharmaceutical Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.8.5 Beijing Winsunny Pharmaceutical Recent Developments
- 4.9 Cozaar
- 4.9.1 Cozaar Company Information
- 4.9.2 Cozaar Business Overview
- 4.9.3 Cozaar Losartan Potassium Hydrochlorothiazide Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cozaar Losartan Potassium Hydrochlorothiazide Tablet Product Portfolio
- 4.9.5 Cozaar Recent Developments
5 Global Losartan Potassium Hydrochlorothiazide Tablet Market Scenario by Region
- 5.1 Global Losartan Potassium Hydrochlorothiazide Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region: 2021-2032
- 5.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region: 2021-2026
- 5.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Region: 2027-2032
- 5.3 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Region: 2027-2032
- 5.4 North America Losartan Potassium Hydrochlorothiazide Tablet Market Facts & Figures by Country
- 5.4.1 North America Losartan Potassium Hydrochlorothiazide Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
- 5.4.3 North America Losartan Potassium Hydrochlorothiazide Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Losartan Potassium Hydrochlorothiazide Tablet Market Facts & Figures by Country
- 5.5.1 Europe Losartan Potassium Hydrochlorothiazide Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Losartan Potassium Hydrochlorothiazide Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Losartan Potassium Hydrochlorothiazide Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Losartan Potassium Hydrochlorothiazide Tablet Market Facts & Figures by Country
- 5.7.1 South America Losartan Potassium Hydrochlorothiazide Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
- 5.7.3 South America Losartan Potassium Hydrochlorothiazide Tablet Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Losartan Potassium Hydrochlorothiazide Tablet Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021-2032)
- 6.1.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Losartan Potassium Hydrochlorothiazide Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021-2032)
- 7.1.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Losartan Potassium Hydrochlorothiazide Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Losartan Potassium Hydrochlorothiazide Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Losartan Potassium Hydrochlorothiazide Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Losartan Potassium Hydrochlorothiazide Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Losartan Potassium Hydrochlorothiazide Tablet Value Chain Analysis
- 8.1.1 Losartan Potassium Hydrochlorothiazide Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Losartan Potassium Hydrochlorothiazide Tablet Production Mode & Process
- 8.2 Losartan Potassium Hydrochlorothiazide Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Losartan Potassium Hydrochlorothiazide Tablet Distributors
- 8.2.3 Losartan Potassium Hydrochlorothiazide Tablet Customers
9 Global Losartan Potassium Hydrochlorothiazide Tablet Analyzing Market Dynamics
- 9.1 Losartan Potassium Hydrochlorothiazide Tablet Industry Trends
- 9.2 Losartan Potassium Hydrochlorothiazide Tablet Industry Drivers
- 9.3 Losartan Potassium Hydrochlorothiazide Tablet Industry Opportunities and Challenges
- 9.4 Losartan Potassium Hydrochlorothiazide Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst